Study Shows Efficacy of Treatment for Preventing Hereditary Angioedema Attacks

Trudy Horsting - October 21, 2019

Autoimmune peripheral neuropathyInflammatory Bowel DiseaseMultiple Sclerosis

The Open Targets Initiative Brings Scientists Closer to Identifying the Cause of Autoimmune Diseases

Friedreich ataxia

Patients Recruited for Phase 2 Study of Experimental Friedreich’s Ataxia Treatment

Rare DiseaseRett Syndrome

Their Daughter Was Maturing Slowly. Then, She Began to Regress.

LATEST PATIENT WORTHY ARTICLES

Native American myopathy

Health Disparities in Native American Communities

This week, many cities and regions across the country acknowledged Indigenous Peoples’ Day, a day to remember and honor the histories and cultures of Native

Duchenne Muscular Dystrophy

Study Analyzes New Outcome Measure for Duchenne Muscular Dystrophy

According to a story from BioSpace, a global collaborative called the Trajectory Analysis Project recently released a study that utilized the North Star Ambulatory Assessment

Cancer

Supplies of a Critical Bladder Cancer Drug are Dwindling

Supplies of a Critical Bladder Cancer Drug are Dwindling Bob Field, a 72-year-old New York banking executive, received a call from his urologist’s office canceling

Huntington's disease

New Partnership Aims to Develop Treatment for Huntington’s Disease

According to a story from ncbiotech.org, a new partnership between Vertex Pharmaceuticals and RNA-based therapeutics company Ribometrix aims to develop potential treatments for serious diseases,

Canavan disease

Found: Pelizaeus-Merzbacher Disease, the Cause, and a Potential Cure

According to a recent article published by the University of California San Francisco, Pelizaeus-Merzbacher disease (PMD) is a rare neurological disease affecting young boys. PMD fatalities

Amyotrophic Lateral Sclerosis

Company Awarded Grant to Conduct Amyotrophic Lateral Sclerosis Clinical Trial

According to a story from PR Newswire, the biopharmaceutical company Clene Nanomedicine, Inc., has issued an announcement in regards to its Australian subsidiary. This subsidiary